Directory
>
Jill Fiedler-Kelly
Jill Fiedler-Kelly
President, Clinical Pharmacology & Pharmacometrics Services at Simulations Plus, Inc | Simulations Plus, Inc.
Buffalo, New York, United States
Jill Fiedler-Kelly
Summary
Jill Fiedler-Kelly is an accomplished leader in the field of clinical pharmacology and pharmacometrics, currently serving as President at Simulations Plus, Inc. With a rich academic background and extensive experience in both corporate and academic settings, she bridges the gap between research and practical application in drug development. Jill has a strong focus on biomarkers and clinical trials, showcasing her expertise in pharmacokinetics and pharmacodynamics. As an adjunct professor at the University at Buffalo, she contributes to the education of future professionals in the pharmaceutical sciences. Her leadership roles at Cognigen Corporation and Simulations Plus highlight her ability to drive innovation in the life sciences sector. Jill's published work on population pharmacokinetic analysis demonstrates her commitment to advancing knowledge in her field. She is passionate about fostering collaboration between academia and industry to enhance drug discovery processes.
Jill Fiedler-Kelly
Work Experience
President, Clinical Pharmacology & Pharmacometrics Services at Simulations Plus, Inc at
Simulations Plus, Inc.
August 2023 - Present
President at
Thaddeus H Grasela
October 2019 - Present
Adjunct Professor at
Univeristy of Buffalo
December 2001 - Present
Owner at
COGNIGEN
November 1992 - September 2014
Research Associate at
Univeristy of Buffalo
September 1989 - November 1992
Jill Fiedler-Kelly
Education
Rochester Institute of Technology, Master Of Science (Ms)
State University of New York at Buffalo, Bachelor's Degree
Frequently Asked Questions about Jill Fiedler-Kelly
What is Jill Fiedler-Kelly email address?
Jill Fiedler-Kelly's primary email address is ****@simulations-plus.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Jill Fiedler-Kelly work for?
Jill Fiedler-Kelly is a President, Clinical Pharmacology & Pharmacometrics Services at Simulations Plus, Inc at Simulations Plus, Inc., a company specializing in Computer terminals.
Where Jill Fiedler-Kelly graduated from?
Jill Fiedler-Kelly holds a degree in Applied And Mathematical Statistics from Rochester Institute of Technology.
How can I directly contact Jill Fiedler-Kelly?
To contact Jill Fiedler-Kelly directly, you can use the email address ****@simulations-plus.com. Complete contact information is available upon registration with Muraena.
Who is Jill Fiedler-Kelly?
Jill Fiedler-Kelly is an accomplished leader in the field of clinical pharmacology and pharmacometrics, currently serving as President at Simulations Plus, Inc. With a rich academic background and extensive experience in both corporate and academic settings, she bridges the gap between research and practical application in drug development. Jill has a strong focus on biomarkers and clinical trials, showcasing her expertise in pharmacokinetics and pharmacodynamics. As an adjunct professor at the University at Buffalo, she contributes to the education of future professionals in the pharmaceutical sciences. Her leadership roles at Cognigen Corporation and Simulations Plus highlight her ability to drive innovation in the life sciences sector. Jill's published work on population pharmacokinetic analysis demonstrates her commitment to advancing knowledge in her field. She is passionate about fostering collaboration between academia and industry to enhance drug discovery processes.
Jill`s contact details
****@simulations-plus.com
******************@cognigencorp.com
*************@buffalo.edu
Colleagues
President, Regulatory Strategies
Chief Executive Officer
Executive Vice President
Associate Vice President, Software Business Development
Associate Vice President, Global Head of Business Development, Services
Executive Director
Executive Director Human Resources
Executive Director of Operations
VP, PBPK Product Development
Vice President, Business Integration and Transformation